What's New
[3/30] Á¦8Â÷ Ç÷¾×Á¾¾ç³»°ú ¿¬¼ö°­ÁÂ
°ü¸®ÀÚ | 2002-02-21 ¿ÀÈÄ 4:56:37 |  Á¶È¸ 3052

Á¦8Â÷ Ç÷¾×Á¾¾ç³»°ú ¿¬¼ö°­Á°¡ ´ÙÀ½°ú °°ÀÌ °³Ãֵ˴ϴÙ.
½Ã°£ : 3¿ù 30ÀÏ (Åä) ¿ÀÀü10½Ã-¿ÀÈÄ5½Ã 40ºÐ
Àå¼Ò : ¼­¿ï´ëÇк´¿ø ÀÓ»óÀÇÇבּ¸¼Ò ´ë°­´ç

´ë»ó : Ç÷¾×Á¾¾ç³»°ú Àü¹®ÀÇ, °³¿øÀÇ, ÀüÀÓÀÇ, Àü°øÀÇ
¿¬¼öÆòÁ¡: ´ëÇÑÀÇ»çÇùȸ 6ÆòÁ¡, ´ëÇѳ»°úÇÐȸ Ç÷¾×Á¾¾ç³»°úºÐ°úÀü¹®ÀÇ 6ÆòÁ¡

½ÅûÁÖ¼Ò: 110-744 ¼­¿ï½Ã Á¾·Î±¸ ¿¬°Çµ¿ 28 ¼­¿ï´ëÇб³º´¿ø Ç÷¾×Á¾¾ç³»°ú
Tel:02-760-2199, Fax:02-742-6689, E-mail:kimty@snu.ac.kr

»çÀüµî·Ï ¸¶°¨Àº 3¿ù 9ÀÏÀ̸ç FAX ¶Ç´Â ¼­¿ï´ëÇб³ Ç÷¾×Á¾¾ç³»°ú
ȨÆäÀÌÁö(http://hmo.snu.ac.kr)¸¦ ÅëÇÏ¿© µî·ÏÀÌ °¡´ÉÇÕ´Ï´Ù.
»çÀüµî·Ï½Ã ½ÅûÀÎÀÇ ¼º¸íÀ» ÇÊÈ÷ ±âÀÔÇϽðí, ¾Æ·¡ÀÇ ÀºÇ౸Á·ΠÀԱݽÃÄÑ ÁֽʽÿÀ.

¿¹±ÝÁÖ:¹Ú¼±¾ç, Á¶ÈïÀºÇà:¿¬°Çµ¿ ÁöÁ¡, ±¸Á¹øÈ£:367-04-612868
¼ö°­·á : (±³Àç ¹× Áᫎ Á¦°ø)
»çÀüµî·Ï: 4¸¸¿ø »çÀüµî·Ï ¸¶°¨ (2002. 3.9), ÀüÀÓÀÇ/Àü°øÀÇ: 3¸¸¿ø
ÇöÀåµî·Ï: 5¸¸¿ø, ÀüÀÓÀÇ/Àü°øÀÇ: 4¸¸¿ø

************************************************

Ç׾Ͽä¹ýÀÇ ÃֽŠµ¿Çâ 2002
Current Issues of Chemotherapy-2002

10:00-10:10 Introduction

I. ³ëÀÎ ¾ÏȯÀÚÀÇ Ç×¾ÏÄ¡·á
Overview
10:10-10:25 Biology È«¿µ¼± (Ä«Å縯ÀÇ´ë)
10:25-10:40 Geriatric evaluation ±èöȣ (¼­¿ïÀÇ´ë)
10:40-10:55 Pharmacology ±èÁؼ® (°í·ÁÀÇ´ë)
10:55-11:10 Discussion

Management of Elderly Cancer Patients
11:10-11:25 Malignant lymphoma ·ù¹é·Ä (¿øÀڷº´¿ø)
11:25-11:40 Leukemia À±¼º¼ö (¼­¿ïÀÇ´ë)
11:40-11:55 Lung cancer ¹Ú±ÙÄ¥ (¼º±Õ°üÀÇ´ë)
11:55-12:10 Palliative care ±è½Ã¿µ (°æÈñÀÇ´ë)
12:10-12:25 Discussion
12:25-1:30 Lunch

II. Ç׾Ͽä¹ýÀÇ ÃÖ½ÅÁö°ß
New Drugs in Clinic-1
13:30-13:45 Thalidomide in cancer therapy ½Åµ¿º¹ (°¡ÃµÀÇ´ë)
13:45-14:00 Arsenic trioxide for hematologic malignancies Á¤Ã¶¿ø (¼º±Õ°üÀÇ´ë)
14:00-14:15 Temozolomide in brain tumor ¹Ú¿µÀÌ (ÇѸ²ÀÇ´ë)
14:15-14:30 Novel hormonal therapy Á¤Çöö (¿¬¼¼ÀÇ´ë)
14:30-14:45 Discussion

Antibody-Based Therapy
14:45-15:00 Her-2/neu targeted antibody ÀÓ¿µÇõ (¼º±Õ°üÀÇ´ë)
15:00-15:15 CD20 targeted antibody ¾ÈÁø¼® (ÇѸ²ÀÇ´ë)
15:15-15:30 EGFR targeted antibody ±è¿­È« (°í·ÁÀÇ´ë)
15:30-15:45 Discussion

15:45-16:00 Coffee Break

Novel Approach of Chemotherapy
16:00-16:15 Pharmacogenetic-based chemotherapy ±èÅÂÀ¯ (¼­¿ïÀÇ´ë)
16:15-16:30 Novel combination chemotherapy in solid tumors ¹Ú¿µ¼® (±¹¸³¾Ï¼¾ÅÍ)
16:30-16:45 Discussion

New Drugs in Clinic-2
16:45-17:00 STI571 in malignant GIST °­À±±¸ (¿ï»êÀÇ´ë)
17:00-17:15 New drugs in clinical trials ¹æ¿µÁÖ (¼­¿ïÀÇ´ë)
17:15-17:30 Ethics of anticancer drug approval Çã´ë¼® (¼­¿ïÀÇ´ë)
17:30-17:45 Discussion

17:30-17:40 Closing remark